| 831 |
Centers for Disease Control and Prevention |
Html |
en |
CDC Grand Rounds: Reducing the Burden of HPV-Associated Cancer and Disease |
This is another in a series of occasional MMWR reports titled CDC Grand Rounds. These reports are based on grand rounds presentations at CDC on high-profile issues in public health science, practice, and policy. Information about CDC Grand Rounds is available at http://www. |
| papilloma virus vaccine | 0.493764 |
| United States | 0.664529 |
| HPV vaccine introduction | 0.599547 |
| oropharyngeal cancers | 0.493781 |
| HPV vaccine | 0.931899 |
| HPV types | 0.67319 |
| vaccine efficacy | 0.505171 |
| prophylactic HPV vaccines | 0.571432 |
| Evidence-Based HPV Prevention | 0.566772 |
| vaginal intraepithelial neoplasia | 0.486325 |
| Engl J Med | 0.496612 |
| vaccine doses | 0.491907 |
| prophylactic human papillomavirus | 0.540648 |
| HPV-16/18 AS04-adjuvanted vaccine | 0.492256 |
| quadrivalent human papillomavirus | 0.547161 |
| meningococcal conjugate vaccine | 0.504259 |
| HPV vaccination coverage | 0.729851 |
| quadrivalent hpv vaccine | 0.710952 |
| vaccination coverage levels | 0.484596 |
| adolescent HPV vaccination | 0.595548 |
| cause cervical cancers | 0.483775 |
| CDC Grand Rounds | 0.483898 |
| HPV vaccination program | 0.586166 |
|
| anal intraepithelial neoplasia | 0.490417 |
| Vaccine Adverse Event | 0.504871 |
| vaccine HPV types | 0.623133 |
| human papillomavirus vaccination | 0.507733 |
| Vaccine Safety Datalink | 0.538842 |
| papillomavirus quadrivalent vaccine | 0.560537 |
| AS04-adjuvanted vaccine | 0.52012 |
| HPV disease prevention | 0.561 |
| HPV vaccines | 0.572166 |
| HPV prevalence | 0.53953 |
| HPV-associated anal cancers | 0.483178 |
| HPV Prevention | 0.571509 |
| Mucosal HPV types | 0.587967 |
| high-risk hpv | 0.566538 |
| human papillomavirus | 0.70264 |
| et al | 0.65739 |
| National HPV vaccination | 0.597633 |
| oncogenic HPV types | 0.595889 |
| HPV type distribution | 0.553905 |
| continued prophylactic efficacy | 0.498125 |
| human papillomavirus vaccine | 0.531954 |
| anal HPV infection | 0.592827 |
|
CLICK HERE |
| 6263 |
Centers for Disease Control and Prevention |
Html |
en |
FASD Competency-Based Curriculum Development Guide for Medical and Allied Health Education and Practice |
FASDs are 100% preventable if a woman does not drink alcohol during pregnancy. There is no known safe amount of alcohol to drink while pregnant. There is also no safe time during pregnancy to drink and no safe kind of alcohol. |
| list Skip | 0.306161 |
| FASD Regional Training | 0.912535 |
| sample teaching tools | 0.260796 |
| Regional Training Centers | 0.751594 |
|
| FASD Competency-Based Curriculum | 0.476535 |
| page options Skip | 0.450287 |
| fetal alcohol spectrum | 0.318919 |
| Allied Health Education | 0.315274 |
|
CLICK HERE |
| 6628 |
Centers for Disease Control and Prevention |
Html |
null |
Chemical Class - Warfare and Terrorism Agents used in acts of war or terror |
Warfare or terrorism agents are a class that includes chemicals, biological substances, radioactive materials, nuclear materials, or explosives. These agents can be used in war against enemies or to frighten groups of individuals. |
|
|
CLICK HERE |
| 8240 |
Centers for Disease Control and Prevention |
Html |
en |
Hemophilia, Video - NCBDDD |
Hemophilia is an inherited bleeding disorder in which the blood does not clot properly. The mission of CDC’s Division of Blood Disorders is to reduce the morbidity and mortality from blood disorders through comprehensive public health practice. |
| UDC Annual Visit | 0.531389 |
| medical home model | 0.530876 |
| demonstration video | 0.542025 |
| Safe | 0.412421 |
| shoulder flexion | 0.558602 |
| elbow pronation | 0.512171 |
| joint disease | 0.463126 |
| key points | 0.460007 |
| Western | 0.412672 |
| impetus | 0.416783 |
| health care reform | 0.527497 |
| joint range | 0.759103 |
| annual visit form | 0.71728 |
| supination | 0.41903 |
| definitions | 0.421081 |
| Conclusion | 0.412371 |
| module | 0.628574 |
| hemophilia talk | 0.497846 |
| friends | 0.4353 |
| Pacific Northwest States | 0.530613 |
| accurate readings | 0.460696 |
| hip flexion | 0.565511 |
| motion measurements | 0.464922 |
| proper way | 0.807312 |
| demonstration | 0.545184 |
|
| hip extension | 0.466572 |
| benefits | 0.412759 |
| extension | 0.469819 |
| ankle dorsiflexion | 0.510474 |
| United States | 0.471113 |
| plantar flexion | 0.604003 |
| practice patient | 0.462688 |
| friend Billy questions | 0.517388 |
| HTC patient | 0.47769 |
| Mountain | 0.412666 |
| comprehensive hemophilia care | 0.566839 |
| elbow flexion | 0.600544 |
| goniometer | 0.485779 |
| smart decisions | 0.463147 |
| knee flexion | 0.620248 |
| measurement techniques | 0.46861 |
| motion demonstration video | 0.540544 |
| brief introduction | 0.464065 |
| ROM Measurement Procedures | 0.914351 |
| team | 0.412631 |
| Blood Roots Documentary | 0.530639 |
| Motion Reference Guide | 0.517046 |
| UDC Joint Range | 0.540664 |
| HTC clinician pioneers | 0.539435 |
|
CLICK HERE |
| 8907 |
Centers for Disease Control and Prevention |
Html |
en |
MMWR - June 14, 2013, Appendix F: Management of the IUD when a Cu-IUD or an LNG-IUD User Is Found To Have Pelvic Inflammatory Disease |
Abbreviations: Cu-IUD = copper-containing IUD; IUD = intrauterine device; LNG-IUD = levonorgestrel-releasing IUD; PID = pelvic inflammatory disease. |
| date | 0.437014 |
| endorsement | 0.561909 |
| woman | 0.441979 |
| Alternate Text | 0.666649 |
| Human Services | 0.870012 |
| Superintendent | 0.451851 |
| levonorgestrel-releasing IUD | 0.76528 |
| Users | 0.435058 |
| URL | 0.439621 |
| content | 0.437674 |
| U.S. Department | 0.85994 |
| MMWR HTML versions | 0.824232 |
| MMWR readers | 0.648994 |
| character translation | 0.623627 |
| identification | 0.441122 |
| pages | 0.437639 |
| U.S. Government Printing | 0.79612 |
| MMWR paper copy | 0.82176 |
| electronic PDF version | 0.801877 |
| publication | 0.43698 |
| intrauterine device | 0.693148 |
| http://www.cdc.gov/mmwr | 0.43491 |
| format errors | 0.644424 |
| flow chart | 0.665243 |
|
| **Questions | 0.435025 |
| Health | 0.475467 |
| Contact GPO | 0.70074 |
| typeset documents | 0.650056 |
| trade names | 0.659378 |
| commercial sources | 0.659033 |
| paper copy | 0.827388 |
| official text | 0.616887 |
| pelvic inflammatory disease | 0.915637 |
| Appendix | 0.462364 |
| current prices | 0.618889 |
| copper-containing IUD | 0.765925 |
| non-CDC sites | 0.639684 |
| management | 0.442109 |
| cdc.gov | 0.434804 |
| original paper copy | 0.805104 |
| References | 0.438414 |
| organizations | 0.438001 |
| messages | 0.434991 |
| Internet | 0.438311 |
| programs | 0.437949 |
| electronic conversions | 0.628078 |
| articles | 0.436124 |
|
CLICK HERE |
| 9153 |
Centers for Disease Control and Prevention |
Html |
en |
Investigation of Hepatitis E Outbreak Among Refugees - UpperNile, South Sudan, 2012-2013 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| acute viral hepatitis | 0.463722 |
| Jamam camp | 0.649653 |
| HEV vaccine | 0.647552 |
| symptomatic HEV infection | 0.57019 |
| HEV infections | 0.538134 |
| Jamam refugee camp | 0.451322 |
| HEV outbreak control | 0.612997 |
| AJS case-fatality rate | 0.480057 |
| CDC-Kenya Medical Research | 0.448236 |
| HEV preventive hygiene | 0.589339 |
| Yusuf Batil camp | 0.44745 |
| AJS attack rates | 0.454469 |
| pregnant women | 0.96966 |
| HEV prevention | 0.540999 |
| South Sudan Ministry | 0.747228 |
| AJS patients | 0.490798 |
| Medical Research Institute | 0.448909 |
| Maban County | 0.458181 |
| active case finding | 0.45245 |
| Yusuf Batil | 0.695766 |
| HEV infection | 0.780637 |
| World Health Organization | 0.586424 |
| Maban County refugee | 0.455854 |
| cumulative hospital CFR | 0.447555 |
| South Sudan | 0.93203 |
|
| Large HEV outbreaks | 0.646016 |
| HEV incubation period | 0.56767 |
| HEV transmission | 0.529226 |
| viral AJS etiologies | 0.4865 |
| AJS cases | 0.645874 |
| prior HEV infection | 0.581258 |
| MУЉdecins Sans FrontiУЈres | 0.53197 |
| Nations High Commissioner | 0.728402 |
| acute jaundice syndrome | 0.559416 |
| Subsequent AJS cases | 0.490155 |
| hygiene conditions | 0.44848 |
| HEV cases | 0.556766 |
| United Nations High | 0.462323 |
| Research Institute laboratory | 0.449581 |
| Global Health Protection | 0.458301 |
| newly developed HEV | 0.612704 |
| HEV genotype | 0.531702 |
| HEV outbreaks | 0.714312 |
| Yusuf Batil refugee | 0.48939 |
| past HEV infection | 0.577665 |
| Batil refugee camps | 0.477944 |
| initial AJS cases | 0.494891 |
| HEV | 0.909412 |
| series HEV vaccine | 0.573147 |
|
CLICK HERE |
| 12846 |
Centers for Disease Control and Prevention |
Html |
en |
Disease Burden of Influenza |
Links to key resources on the burden of influenza - CDC |
| Flu Vaccine Saved | 0.262093 |
| influenza season | 0.528031 |
| Fukuda K. | 0.355994 |
| United States | 0.795892 |
| seasonal influenza | 0.360354 |
| K. Influenza-associated hospitalizations | 0.496936 |
| Hospitalization Surveillance Network | 0.29196 |
| influenza vaccination | 0.508088 |
| MMWR Morb Mortal | 0.911799 |
| Clin Infect Dis. | 0.31827 |
| Bridges CB | 0.309989 |
| Shay DK | 0.950958 |
|
| Bresee JS | 0.209581 |
| pediatric respiratory hospitalizations | 0.453118 |
| Infect Dis. | 0.331956 |
| Fukuda K. Mortality | 0.294183 |
| estimated influenza illnesses | 0.795108 |
| Mortal Wkly Rep | 0.862475 |
| Emerg Infect Dis. | 0.304101 |
| cdc. estimated influenza | 0.787322 |
| respiratory syncytial virus | 0.581492 |
| Cheng PY | 0.547555 |
| Thompson WW | 0.453615 |
|
CLICK HERE |
| 12895 |
Centers for Disease Control and Prevention |
Video |
en |
Concussion Videos - Kurt Warner's Story (Football) |
null |
|
|
CLICK HERE |
| 13156 |
Centers for Disease Control and Prevention |
Html |
en |
Chagas Disease | Podcasts | CDC |
Podcasts on Chagas Disease. |
| National Center | 0.270189 |
| list Skip | 0.42733 |
| United States Blood | 0.650877 |
| page options Skip | 0.591476 |
| Vector-borne Transmission | 0.546634 |
| infected patients | 0.282065 |
| Date Released | 0.273812 |
| Trypanosoma cruzi Infection | 0.847382 |
|
| navigation Skip | 0.426642 |
| States Blood Donors | 0.699051 |
| Congenital Transmission | 0.49287 |
| chagas disease | 0.988151 |
| United States Trypanosoma | 0.720431 |
| Enteric Diseases | 0.287434 |
| cruzi Infection Study | 0.78498 |
|
CLICK HERE |
| 15556 |
Centers for Disease Control and Prevention |
Html |
en |
What Is the National DPP? |
National Diabetes Prevention Program |
| prevention program | 0.238594 |
| lifestyle change programs | 0.869514 |
| overall health | 0.251367 |
| diabetes prevention efforts | 0.304888 |
| Prevent Diabetes STAT | 0.38602 |
| lifestyle change program | 0.374789 |
| lifestyle coach | 0.218524 |
| National DPP | 0.911561 |
| Research-Based Prevention Program | 0.22861 |
| National Diabetes Prevention | 0.333636 |
|
| online CDC-recognized lifestyle | 0.269295 |
| CDC-recognized lifestyle change | 0.4518 |
| lasting lifestyle changes | 0.282267 |
| National DPP Infographic | 0.510621 |
| online lifestyle change | 0.283756 |
| nationwide teach participants | 0.228048 |
| public awareness campaign | 0.226045 |
| American Diabetes Association | 0.282812 |
| health care providers | 0.222582 |
|
CLICK HERE |